Discover 521 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Calgary runs one of the busiest research programs in western Canada, with hundreds of studies recruiting at any given time.The Arthur J.E. Child Comprehensive Cancer Centre opened in Calgary in October 2024, making cancer research the city's fastest-growing trial area. Roughly a third of Calgary's recruiting studies are in oncology, and the rest cluster around heart failure, kidney disease, and metabolic conditions, much of it run through the University of Calgary. The city is also unusual for the volume of paediatric research at Alberta Children's Hospital, so families often find studies here that are not available elsewhere in the province.
Filter
2
Filter results
Results: 521
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for
Superficial Bladder Cancer,
Location: Calgary, Vancouver, Portland OR, Salt Lake City UT,
Sponsor: enGene, Inc.
Sex: All
Age: 18+
Code: NCT04752722
Phase 1, Phase 2, Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Calgary, Spokane WA, Portland OR, Denver CO, Fresno CA,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase 3, Recruiting
Surveillance of Complex Renal Cysts - The SOCRATIC Study
for
Complex Renal Cyst
Location: Calgary, Edmonton, Vancouver, Winnipeg, Thunder Bay,
Sponsor: Université de Sherbrooke
Sex: All
Age: 18+
Code: NCT04558593
Recruiting
PSMA-Guided Ablation of the Prostate
for
Prostate Cancer, Localized Prostate Carcinoma
Location: Calgary, Edmonton, Toronto
Sponsor: University of Alberta
Sex: Male
Age: 50+
Code: NCT06003556
Phase 2, Recruiting
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Clinical Trial in Patients With Barth Syndrome- 4TAZPower
for
Barth Syndrome
Location: Calgary
Sponsor: Stealth BioTherapeutics Inc.
Sex: Male
Age: 5 - 55
Code: NCT07531251
Recruiting
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
for
Niemann-Pick Type C Disease, GM1 Gangliosidosis,
Location: Calgary, Oakland CA, Minneapolis MN, Rochester MN,
Sponsor: Azafaros B.V.
Sex: All
Age: 4+
Code: NCT07054515
Phase 3, Recruiting
Pharmacist CVD Intervention for Patients With Inflammatory Arthritis